Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026
One of these pharmaceutical leaders overcame a major obstacle and has a strong outlook. The other is actively…
Do These 3 Healthcare Stocks Need a Checkup?
Pfizer has a sizable 6.8% yield and is down nearly 60% from its 2021 highs. Bristol Myers Squibb…
U.S. Negotiates Lower Prices for Ozempic and 14 Other Drugs
The U.S. government negotiated lower prices in the federal Medicare program for 15 high-selling medicines including Ozempic, widening…
2 Strong Healthcare Stock Picks for Value Investors
These two tried-and-tested healthcare giants have compelling portfolios and pipelines. Pfizer is moving on from the pandemic era,…
Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as…
MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOE
Merck’s MRK blockbuster PD-L1 inhibitor, Keytruda, approved for several types of cancer indications, is the company’s biggest revenue…